J L Becker1, V Patel2, K J Johnson2, M Guerrero3, R R Klein4, G F Ranvier5, R P Owen5, P Pawha6, K Nael6,7. 1. From the Departments of Medical Imaging (J.L.B., V.P., K.J.J.) jbecker@radiology.arizona.edu. 2. From the Departments of Medical Imaging (J.L.B., V.P., K.J.J.). 3. Surgery (M.G.). 4. Pathology (R.R.K.), University of Arizona, Tucson, Arizona. 5. Departments of Surgery (G.F.R., R.P.O.). 6. Radiology (P.P., K.N.), Icahn School of Medicine at Mount Sinai, New York, New York. 7. Department of Radiological Sciences (K.N.), David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
Abstract
BACKGROUND AND PURPOSE: Our aim was to test the hypothesis that our recently introduced 4D-dynamic contrast-enhanced MR imaging with high spatial and temporal resolution has equivalent accuracy to 4D-CT for preoperative gland localization in primary hyperparathyroidism without requiring exposure to ionizing radiation. MATERIALS AND METHODS: Inclusion criteria were the following: 1) confirmed biochemical diagnosis of primary hyperparathyroidism, 2) preoperative 4D-dynamic contrast-enhanced MR imaging, and 3) surgical cure with >50% decrease in serum parathyroid hormone intraoperatively. 4D-dynamic contrast-enhanced studies were reviewed independently by 2 neuroradiologists to identify the side, quadrant, and number of abnormal glands, and compared with surgical and pathologic results. RESULTS: Fifty-four patients met the inclusion criteria: 37 had single-gland disease, and 17, multigland disease (9 with double-gland hyperplasia; 3 with 3-gland hyperplasia; and 5 with 4-gland hyperplasia). Interobserver agreement (κ) for the side (right versus left) was 0.92 for single-gland disease and 0.70 for multigland disease. Interobserver agreement for the quadrant (superior versus inferior) was 0.70 for single-gland disease and 0.69 for multigland disease. For single-gland disease, the gland was correctly located in 34/37 (92%) patients, with correct identification of the side in 37/37 (100%) and the quadrant in 34/37 (92%) patients. For multigland disease, the glands were correctly located in 35/47 (74%) patients, with correct identification of the side in 35/47 (74%) and the quadrant in 36/47 (77%). CONCLUSIONS: The proposed high spatial and temporal resolution 4D-dynamic contrast-enhanced MR imaging provides excellent diagnostic performance for preoperative localization in primary hyperparathyroidism, with correct gland localization of 92% for single-gland disease and 74% in multigland disease, superior to 4D-CT studies.
BACKGROUND AND PURPOSE: Our aim was to test the hypothesis that our recently introduced 4D-dynamic contrast-enhanced MR imaging with high spatial and temporal resolution has equivalent accuracy to 4D-CT for preoperative gland localization in primary hyperparathyroidism without requiring exposure to ionizing radiation. MATERIALS AND METHODS: Inclusion criteria were the following: 1) confirmed biochemical diagnosis of primary hyperparathyroidism, 2) preoperative 4D-dynamic contrast-enhanced MR imaging, and 3) surgical cure with >50% decrease in serum parathyroid hormone intraoperatively. 4D-dynamic contrast-enhanced studies were reviewed independently by 2 neuroradiologists to identify the side, quadrant, and number of abnormal glands, and compared with surgical and pathologic results. RESULTS: Fifty-four patients met the inclusion criteria: 37 had single-gland disease, and 17, multigland disease (9 with double-gland hyperplasia; 3 with 3-gland hyperplasia; and 5 with 4-gland hyperplasia). Interobserver agreement (κ) for the side (right versus left) was 0.92 for single-gland disease and 0.70 for multigland disease. Interobserver agreement for the quadrant (superior versus inferior) was 0.70 for single-gland disease and 0.69 for multigland disease. For single-gland disease, the gland was correctly located in 34/37 (92%) patients, with correct identification of the side in 37/37 (100%) and the quadrant in 34/37 (92%) patients. For multigland disease, the glands were correctly located in 35/47 (74%) patients, with correct identification of the side in 35/47 (74%) and the quadrant in 36/47 (77%). CONCLUSIONS: The proposed high spatial and temporal resolution 4D-dynamic contrast-enhanced MR imaging provides excellent diagnostic performance for preoperative localization in primary hyperparathyroidism, with correct gland localization of 92% for single-gland disease and 74% in multigland disease, superior to 4D-CT studies.
Authors: Amit Mahajan; Lee F Starker; Monica Ghita; Robert Udelsman; James A Brink; Tobias Carling Journal: World J Surg Date: 2012-06 Impact factor: 3.352
Authors: Melinda M Mortenson; Douglas B Evans; Jeffrey E Lee; George J Hunter; Dawid Shellingerhout; Thinh Vu; Beth S Edeiken; Lei Feng; Nancy D Perrier Journal: J Am Coll Surg Date: 2008-03-24 Impact factor: 6.113
Authors: A J Krubsack; S D Wilson; T L Lawson; J B Kneeland; M K Thorsen; B D Collier; R S Hellman; A T Isitman Journal: Surgery Date: 1989-10 Impact factor: 3.982
Authors: Michael D Beland; William W Mayo-Smith; David J Grand; Jason T Machan; Jack M Monchik Journal: AJR Am J Roentgenol Date: 2011-01 Impact factor: 3.959
Authors: Allison M Grayev; Lindell R Gentry; Michael J Hartman; Herbert Chen; Scott B Perlman; Scott B Reeder Journal: Ann Surg Oncol Date: 2011-08-31 Impact factor: 5.344
Authors: Yaqi Shen; Frank L Goerner; Christopher Snyder; John N Morelli; Dapeng Hao; Daoyu Hu; Xiaoming Li; Val M Runge Journal: Invest Radiol Date: 2015-05 Impact factor: 6.016
Authors: Michael A Morris; Babak Saboury; Mark Ahlman; Ashkan A Malayeri; Elizabeth C Jones; Clara C Chen; Corina Millo Journal: Front Endocrinol (Lausanne) Date: 2022-02-25 Impact factor: 5.555